Program of the 9th Japan-China International Symposium on Health Sciences
(The Auditorium, University of Shizuoka / October 14, 2010)
Naohide Kinae (President, University of Shizuoka)
Shen Zheng-rong (Deputy President, Zhejiang Academy of Medical Sciences)
Chairperson: Toshiyuki Kan and Ye Yi-ping
Professor, School of Pharmaceutical Sciences, University of Shizuoka Novel heart failure therapy targeting transcriptional pathway in cardiomyocytes by a natural compound, curcumin ……………………… (1)
Associate Professor, Head, Multidisciplinary Unit and Department of Pharmacology, Faculty of Science, Mahidol University Studies on the pharmacological effect of Ganoderma lucidum: Thai experience …………………………………………………………………… (2)
Professor, School of Pharmaceutical Sciences, University of Shizuoka Dissolution profile in relation to the available surface area of drug in tablet …………………………………………………………………………………… (3)
Associate Professor, Deputy Director, Institute of Materia Medica, Zhejiang Academy of Medical Sciences Constituents from Stephanotis mucronata and their immunological activities …………………………………………………………………………………… (4)
Chairperson: Tsutomu Nakayama and Krongtong Yoovathaworn
Associate Professor, Graduate School of Nutritional and Environmental Sciences, University of Shizuoka Interaction targeting: Directed evolution of target-binding peptides using a quantitative high-throughput yeast two-hybrid screening system ……… (5)
Graduate School of Pharmaceutical Sciences, University of Shizuoka Lubrication properties of potential alternative lubricants, glycerin fatty acid esters, to magnesium stearate ……………………………………………… (6)
Institute of Materia Medica, Zhejiang Academy of Medical Sciences Effects of thioglycolic acid on progesterone-induced maturation of Xenopus oocytes …………… ………………………………………………………… (7)
Graduate School of Pharmaceutical Sciences, University of Shizuoka Disintegration and dissolution behavior of clarithromycin tablets under low pH conditions ………………………………………………………………… (8)
Graduate School of Pharmaceutical Sciences, University of Shizuoka Neuroprotective effects of AEPO-modified liposome on cerebral ischemia-reperfusion injury ………………………………………………… (9)
Lunch (12:00 –13:00) Session III (13:00 –14:30)
Professor, Laboratory Chief, Institute of Bioengineering, Zhejiang Academy of Medical Sciences Experimental infection of ZCLA Mongolian Gerbils with hepatitis E virus ………………………………………………………………………………… (10)
Associate professor, School of Pharmaceutical Sciences, University of Shizuoka Binding mode prediction and rational design of diketo acid derivatives targeting metalloenzyme RNA polymerase of influenza virus…………… (11)
Professor, Director, Institute of Parasitic Diseases, Zhejiang Academy of Medical Sciences A new rapid serological diagnostic technique for detecting of anti-Schistosoma japonica antibody …………………………………… (12)
Graduate School of Pharmaceutical Sciences, University of Shizuoka Antiviral effect of strictinin on influenza virus replication ……………… (13)
Graduate School of Nutritional and Environmental Sciences, University of Shizuoka Molecular detection of tick-borne Rickettsia-related bacteria in western Japan ………………………………………………………………………… (14)
Institute of Materia Medica, Zhejiang Academy of Medical Sciences Studies on enantioselectivity and the implication of formulation factors with respect to percutaneous permeation of chiral drugs ………………… (15)
Tea Break (14:30 –15:00) Session IV (15:00 –16:00)
Associate Professor, School of Food and Nutritional Sciences, University of Shizuoka Type 2 diabetes and cancer risk among Japanese according to changes in food intake …………………………………………………………………… (16)
Professor, Laboratory Chief, Institute of Materia Medica, Zhejiang Academy of Medical Sciences Identification and characterization of peptide inhibitors targeting transcription factor ERG in prostate cancer …………………………………………… (17)
Associate Professor, Graduate School of Nutritional and Environmental Sciences, University of Shizuoka Estrogenic activity of alkyl(thio)phenols formed from degradation of commercial organophosphorus insecticides …………………………… (18)
Chairperson: Masahiro Sakata and Wang Xiao-ju
Professor, Director, Institute of Hygiene, Zhejiang Academy of Medical Sciences p,p’-DDE induced testicular apoptosis via the mitochondrial pathway ………………………………………………………………………………… (19)
Graduate School of Pharmaceutical Sciences, University of Shizuoka Development of a new high-throughput assay targeting eIF4E protein ………………………………………………………………………………… (20)
Institute of Hygiene, Zhejiang Academy of Medical Sciences Altered expression of FGF-7, IGFBP-5 and calumenin in rats exposed to man-made vitreous fibers ………………………………………………… (21)
Graduate School of Nutritional and Environmental Sciences, University of Shizuoka Industrial solid waste management in Ho Chi Minh City, Vietnam: Status and prospect for sustainable development ………………………………… (22)
Institute of Hygiene, Zhejiang Academy of Medical Sciences Studying the cyto-genotoxic effects of 12 cigarette smoke condensates on human lymphoblastoid cell line in vitro ………………………………… (23)
Naoto Oku (Dean, School of Pharmaceutical Sciences, University of Shizuoka)
Gift Exchange and Group Picture (17:10 - 17:30)
19 Church Avenue, Drumcondra, Dublin 9 - 085 7197714 -July 2011 – Music Co-ordinator for Whitechurch Summer Camp: This involved developing and implementing a music program for 4 – 7 year old children over two 2 week cycles. (Referee Yvonne Beardsley)September 2009 – Present: Bolton School of Music, Carlow: Teaching Irish music on tin whistle, flute and bodhrán to children and adults. (R
Patient Information LEVITRA® (Luh-VEE-Trah) (vardenafil HCl) Tablets HOW SHOULD YOU TAKE LEVITRA? Take LEVITRA exactly as your doctor prescribes. LEVITRA comes in different doses (2.5 mg, 5 mg, 10 mg, and Read the Patient Information about LEVITRA before you start taking it and again each time you get a refill. There may20 mg). For most men, the recommended starting dose is 10 mg.